Index RUT
P/E -
EPS (ttm) -1.57
Insider Own 36.20%
Shs Outstand 68.63M
Perf Week 10.45%
Market Cap 1.01B
Forward P/E -
EPS next Y -0.44
Insider Trans 5.52%
Shs Float 48.73M
Perf Month 0.23%
Income -107.69M
PEG -
EPS next Q -0.34
Inst Own 51.33%
Short Float 16.65%
Perf Quarter -7.33%
Sales 15.97M
P/S 63.18
EPS this Y -11.93%
Inst Trans -4.04%
Short Ratio 10.09
Perf Half Y 108.69%
Book/sh 1.13
P/B 11.68
EPS next Y 67.38%
ROA -66.06%
Short Interest 8.11M
Perf Year 59.16%
Cash/sh 2.07
P/C 6.39
EPS next 5Y -
ROE -128.27%
52W Range 5.71 - 16.99
Perf YTD 9.81%
Dividend Est. -
P/FCF -
EPS past 5Y 30.44%
ROI -121.99%
52W High -22.25%
Beta 0.26
Dividend TTM -
Quick Ratio 7.50
Sales past 5Y 423.30%
Gross Margin 68.89%
52W Low 131.35%
ATR (14) 0.60
Dividend Ex-Date -
Current Ratio 7.66
EPS Y/Y TTM -172.43%
Oper. Margin -582.16%
RSI (14) 52.38
Volatility 5.60% 4.52%
Employees 136
Debt/Eq 0.04
Sales Y/Y TTM -5.72%
Profit Margin -674.42%
Recom 1.57
Target Price 24.14
Option/Short Yes / Yes
LT Debt/Eq 0.02
EPS Q/Q -198.95%
Payout -
Rel Volume 0.42
Prev Close 13.35
Sales Surprise -33.58%
EPS Surprise -66.92%
Sales Q/Q -33.85%
Earnings May 14 BMO
Avg Volume 803.97K
Price 13.21
SMA20 4.67%
SMA50 -5.65%
SMA200 28.08%
Trades
Volume 109,678
Change -1.05%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-05-24 Reiterated
Needham
Buy
$18 → $28
Sep-19-22 Resumed
Wedbush
Underperform
$3
Sep-01-22 Downgrade
Wedbush
Neutral → Underperform
$3
Jul-22-22 Initiated
Ladenburg Thalmann
Buy
$15
May-31-22 Initiated
BTIG Research
Buy
$14
May-26-22 Initiated
BofA Securities
Buy
$12
Dec-04-20 Initiated
H.C. Wainwright
Buy
$6
Nov-20-20 Downgrade
Wedbush
Outperform → Neutral
$20 → $4
Nov-08-18 Resumed
Jefferies
Buy
Sep-05-18 Initiated
Wedbush
Outperform
$26
Aug-20-18 Initiated
Needham
Buy
$30
Aug-20-18 Initiated
Jefferies
Buy
$22
Show Previous Ratings
May-15-24 03:03AM
02:05AM
(Thomson Reuters StreetEvents)
May-14-24 09:35AM
08:53AM
May-13-24 05:43PM
08:00AM
Loading…
May-10-24 08:00AM
May-07-24 08:30AM
08:00AM
Apr-25-24 10:02AM
Apr-02-24 09:00AM
Apr-01-24 06:00AM
Mar-20-24 01:50AM
01:49AM
Mar-16-24 02:42PM
Mar-13-24 10:54PM
(Thomson Reuters StreetEvents) +5.36%
07:31AM
Loading…
07:31AM
07:10AM
06:00AM
Mar-06-24 06:30AM
Feb-21-24 03:17PM
06:51AM
06:24AM
Jan-30-24 06:30AM
Jan-29-24 09:55AM
Jan-25-24 06:25AM
06:00AM
Jan-19-24 06:30AM
Jan-09-24 06:21PM
04:56PM
Jan-08-24 08:22AM
06:45AM
Loading…
Jan-05-24 06:45AM
Jan-04-24 09:10AM
Jan-02-24 06:45AM
Dec-29-23 06:45AM
Dec-25-23 08:00AM
Dec-22-23 06:35PM
Dec-20-23 04:56PM
Dec-19-23 01:02PM
Dec-12-23 07:13AM
Nov-08-23 10:47AM
12:44AM
(Thomson Reuters StreetEvents)
Nov-07-23 07:07AM
06:30AM
Oct-31-23 06:30AM
Oct-02-23 07:00AM
Sep-25-23 04:09PM
Sep-06-23 04:30PM
Aug-13-23 05:22AM
Aug-11-23 12:38AM
(Thomson Reuters StreetEvents) -9.13%
Aug-10-23 07:15AM
06:00AM
Aug-03-23 08:17AM
Jul-27-23 09:13AM
06:00AM
Jul-25-23 02:37PM
(American City Business Journals)
08:25AM
(American City Business Journals)
Jul-24-23 01:46PM
Jun-29-23 11:24AM
Jun-28-23 05:36AM
May-31-23 06:30AM
May-30-23 11:26AM
May-21-23 03:39PM
May-19-23 06:15AM
May-09-23 06:33AM
May-04-23 09:15AM
06:30AM
May-02-23 06:45AM
Apr-27-23 06:45AM
Apr-20-23 04:17AM
Apr-18-23 08:33AM
Apr-11-23 06:45AM
Apr-03-23 06:45AM
Mar-25-23 08:33AM
Mar-20-23 04:10AM
Mar-18-23 08:34AM
Mar-17-23 03:22AM
(Thomson Reuters StreetEvents)
Mar-16-23 07:55AM
06:30AM
Mar-09-23 10:00AM
07:19AM
Feb-17-23 07:33AM
Feb-05-23 08:49PM
(American City Business Journals)
Feb-03-23 05:10AM
Feb-02-23 04:39PM
06:30AM
Jan-09-23 10:01PM
(American City Business Journals)
06:30AM
Dec-30-22 09:40AM
Dec-14-22 09:40AM
Dec-05-22 04:05PM
Dec-01-22 09:55AM
Nov-28-22 09:40AM
Nov-08-22 07:45AM
06:30AM
Nov-02-22 10:15AM
Nov-01-22 06:45AM
Oct-27-22 04:10PM
Oct-26-22 09:40AM
Oct-17-22 06:30AM
Sep-26-22 06:45AM
Liquidia Corp. operates as a holding company which through its subsidiary engages in developing and commercializing biopharmaceutical products. It engages in novel products development used in PRINT technology to transform the lives of patients. The company was founded on June 28, 2020, and is headquartered in Morrisville, NC.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Saggar Rajeev Chief Medical Officer Apr 19 '24 Sale 13.68 1,649 22,558 211,672 Apr 23 05:24 PM JEFFS ROGER Chief Executive Officer Apr 12 '24 Sale 14.58 8,360 121,889 826,985 Apr 16 05:15 PM Kaseta Michael CFO and COO Apr 12 '24 Sale 14.58 3,136 45,723 315,045 Apr 16 05:16 PM Schundler Russell General Counsel Apr 12 '24 Sale 14.58 2,060 30,035 486,027 Apr 16 05:17 PM Moomaw Scott Chief Commercial Officer Apr 12 '24 Sale 14.58 1,585 23,109 151,881 Apr 16 05:16 PM Saggar Rajeev Chief Medical Officer Apr 12 '24 Sale 14.58 1,525 22,234 213,321 Apr 16 05:17 PM Adair Jason Chief Business Officer Apr 12 '24 Sale 14.58 1,189 17,336 111,537 Apr 15 08:31 PM JEFFS ROGER Chief Executive Officer Mar 18 '24 Sale 15.82 28,583 452,183 835,345 Mar 19 09:46 PM Kaseta Michael CFO and COO Mar 18 '24 Sale 15.82 12,166 192,466 318,181 Mar 19 09:47 PM Schundler Russell General Counsel Mar 18 '24 Sale 15.82 8,653 136,890 488,087 Mar 19 09:48 PM Saggar Rajeev Chief Medical Officer Mar 18 '24 Sale 15.82 7,530 119,125 214,846 Mar 19 09:46 PM Moomaw Scott Chief Commercial Officer Mar 18 '24 Sale 15.82 6,108 96,629 153,466 Mar 19 09:47 PM Adair Jason Chief Business Officer Mar 18 '24 Sale 15.81 4,657 73,649 108,640 Mar 19 09:50 PM Moomaw Scott Chief Commercial Officer Feb 29 '24 Sale 14.17 546 7,737 159,574 Mar 04 07:07 PM Adair Jason Chief Business Officer Feb 29 '24 Sale 14.17 455 6,447 97,412 Mar 04 07:05 PM Adair Jason Chief Business Officer Dec 18 '23 Sale 7.70 77 593 54,932 Dec 20 05:20 PM Caligan Partners LP Director Dec 14 '23 Buy 7.16 1,117,318 7,999,997 11,280,945 Dec 14 04:42 PM Manning Paul B Director Dec 14 '23 Buy 7.16 279,330 2,000,003 279,330 Dec 18 05:00 PM JEFFS ROGER Chief Executive Officer Dec 14 '23 Buy 7.16 139,665 1,000,001 640,805 Dec 18 05:02 PM Moomaw Scott Chief Commercial Officer Nov 30 '23 Sale 7.28 542 3,946 106,737 Dec 05 09:18 PM Lippe Robert A Chief Operations Officer Nov 30 '23 Sale 7.28 497 3,618 193,788 Dec 05 09:21 PM Adair Jason Chief Business Officer Nov 30 '23 Sale 7.28 452 3,291 54,478 Dec 05 09:15 PM Adair Jason Chief Business Officer Sep 19 '23 Sale 6.51 75 488 53,637 Sep 20 06:14 PM Moomaw Scott Chief Commercial Officer Aug 31 '23 Sale 6.88 537 3,695 105,404 Sep 05 08:10 PM Lippe Robert A Chief Operations Officer Aug 31 '23 Sale 6.88 505 3,474 192,567 Sep 05 08:11 PM Adair Jason Chief Business Officer Aug 31 '23 Sale 6.88 445 3,062 53,452 Sep 05 08:09 PM Moomaw Scott Chief Commercial Officer May 31 '23 Sale 8.08 651 5,260 102,268 Jun 02 05:05 PM Lippe Robert A Chief Operations Officer May 31 '23 Sale 8.08 597 4,824 189,646 Jun 02 05:03 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite